Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2014 Jan;13(1):22-7.
doi: 10.4103/1450-1147.138570.

Preparation and evaluation of Lu-(177) phytate Complex for Radiosynovectomy

Affiliations

Preparation and evaluation of Lu-(177) phytate Complex for Radiosynovectomy

Hassan Yousefnia et al. World J Nucl Med. 2014 Jan.

Retraction in

Abstract

Lu-(177) of 2.6-3 GBq/mg specific activity was obtained by irradiation of natural Lu2O3 sample with thermal neutron flux of 4 × 10(13) n/cm/s. The product was converted into chloride form which was further used for labeling of Lu(-177) phytate complex successfully with high radiochemical purity (>99.9%, instant thin layer chromatography, MeOH: H2O: Acetic acid, 4:4:2, as mobile phase). The complex stability and viscosity were checked in the final solution up to 7 days. The prepared complex solution (100 μCi/100 μl) was injected intra-articularly to the male rat knee joint. Leakage of radioactivity from the injection site and its distribution in organs were investigated up to 7 days. Approximately, all injected dose has remained in injection site 7 days after injection. The complex was proved to be a feasible agent for cavital radiotherapy in oncology and rheumatology.

Keywords: Biodistribution; lutetium-177; phytate; radiosynovectomy.

PubMed Disclaimer

Conflict of interest statement

Conflict of Interest: None declared.

Figures

Figure 1
Figure 1
Chemical formula for phytate
Figure 2
Figure 2
Gamma-ray spectrum for Lu-177 chloride solution used in this study
Figure 3
Figure 3
Instant thin layer chromatography chromatograms of Lu-177Cl3 solution in diethylenetriamene pentaacetate solution (pH = 5) (left) and 10% ammonium acetate:methanol (1:1) solution (right) using Whatman no. 2
Figure 4
Figure 4
Instant thin layer chromatography chromatograms of Lu-177-LuCl3 (left) and Lu-177-phytate solution (right) on Whatman no. 1 paper using methanol:water:acetic acid (4:4:2) mixture
Figure 5
Figure 5
Percentage of injected dose per gram (ID/g %) of Lu-177Cl3 in wild-type rat tissues at 2, 4, 24 and 48 h post injection
Figure 6
Figure 6
Percentage of injected dose per gram (ID/g %) of Lu-177-phytate in wild-type rat tissues at 2 h, 24 h, 5 d and 7 d post intravenous injection
Figure 7
Figure 7
Distribution of [Lu-177]-phytate in wild-type male rats, 4, 24, 120 h and 168 h after intra-articular injection of 100 μCi of compound. % ID-percentage of injected dose. Each bar presents mean± standard deviation (n=3)
Figure 8
Figure 8
Distribution of [Lu-177]-phytate in wild-type male rats excluding injected knee data at 4, 24, 48, 120 h and 144 h after intra-articular injection of 10 μCi of compound. % ID-percentage of injected dose. Each bar presents mean± standard deviation (n=3)
Figure 9
Figure 9
Scintigraphic images of Lu-177-phytate in wild-type rat tissues 1 week post intravenous injection
Figure 10
Figure 10
Scintigraphic images of Lu-177-phytate in wild-type rat knee 1 and 7 days post intra-articular injection

Similar articles

Cited by

References

    1. European Association of Nuclear Medicine (EANM) Procedure Guidelines for Radiosynovectomy. Guidelines issued date: 2002 Oct 4. Available at http://www.snm.org.tw/Guideline/gl_radio_synovectomy.pdf .
    1. Kropácek M, Melichar F, Henková K, Konopková M. Preparation of holmium-166 labelled macroaggregates for radionuclide synovectomy. Nucl Med Rev Cent East Eur. 2003;6:1–4. - PubMed
    1. Suzuki YS, Momose Y, Higashi N, Shigematsu A, Park KB, Kim YM, et al. Biodistribution and kinetics of holmium-166-chitosan complex (DW-166HC) in rats and mice. J Nucl Med. 1998;39:2161–6. - PubMed
    1. Bodei L, Ferone D, Grana CM, Cremonesi M, Signore A, Dierckx RA, et al. Peptide receptor therapies in neuroendocrine tumors. J Endocrinol Invest. 2009;32:360–9. - PubMed
    1. Michel RB, Andrews PM, Rosario AV, Goldenberg DM, Mattes MJ. Lu- 177-antibody conjugates for single-cell kill of B-lymphoma cells in vitro and for therapy of micrometastases in vivo. Nucl Med Biol. 2005;32:269–78. - PubMed

Publication types